nonapeptide hormone

Oxytocin

US: FDA-approvedEU: Not on the registerUK: AuthorisedCA: AuthorisedAU: RegisteredCH: AuthorisedBR: RegistadoRS: AuthorisedSG: RegisteredTR: Ruhsatli

Answer

Oxytocin is authorised or registered in the US, the UK, Canada, Australia, Switzerland, Brazil, Serbia, Singapore and Turkey: 9 of the 10 registers read. Highest trial phase: Phase 4 (after approval). It has 952 registered trials, 125 of them running. Brand names on the FDA label register: Guna-Geriatrics, Intimate, Guna-Awareness and Oxytocin.

RegulatorTrial register10 regulators' registers, read 2026-08-31 to 2026-10-03 · ClinicalTrials.gov and EU CTIS, read 2026-10-03

Not medical, legal or regulatory advice.

Registered trials952Trial register ClinicalTrials.gov and EU CTIS
Running now125Trial register recruiting, active or enrolling
Results posted140Trial register with results on the register
Stopped early9%Trial register all peptides: 10%

952 trials by status

Trial register
Running 125Completed 554Stopped early 86Status unknown 163Other or not stated 24

ClinicalTrials.gov and EU CTIS · read 2026-10-03 · 140 trials have posted results

Trials first submitted per year

Trial register

ClinicalTrials.gov first-submitted date, last 10 years · read 2026-10-03. 2026 is not complete. 424 trials carry no first-submitted date (EU CTIS publishes none, or the year is outside this range).

Status by jurisdiction

World map
Authorised or registeredNot on the register, or withdrawnNot read yet, or status unknown
WhereStatusRegisterRead
United StatesFDA-approvedFDA, openfda2026-10-03
European UnionNot on the registerEMA, ema2026-08-31
United KingdomAuthorisedMHRA, uk-mhra2026-10-03
CanadaAuthorisedHealth Canada, ca-dpd2026-10-03
AustraliaRegisteredTGA, au-artg2026-10-03
SwitzerlandAuthorisedSwissmedic, ch-swissmedic2026-10-03
BrazilRegistadoANVISA, br-anvisa2026-10-03
SerbiaAuthorisedALIMS, rs-alims2026-09-03
SingaporeRegisteredHSA, sg-hsa2026-09-03
TurkeyRuhsatliTITCK, tr-titck2026-09-03

An EU decision applies in the 30 territories the EU register covers: its member states, and Iceland, Liechtenstein and Norway. A dashed tile has no register read for this peptide.

CHANGE ALERTS

Get an email when this changes

One email when the status of Oxytocin changes on the register. You confirm your address first.

REGISTERED TRIALS

Newest 10 of 952 trials

All 952 trials
NCT07853924
Effect of Intravenous Oxytocin on Post Dural Puncture Headache After Caesarean Sections
not yet recruiting participants · register updated 2026-10-02
NCT04306354
Use of Intranasal Oxytocin During Detoxification of Crack Cocaine
completed · register updated 2026-09-28
NCT06757517
Effects of Intranasal Oxytocin in the Treatment of Benzodiazepine Withdrawal: A Pilot RCT
completed · register updated 2026-09-28
NCT07430228
Efficacy of Intravenous Oxytocin to Speed Recovery After THA
enrolling by invitation only · register updated 2026-09-24
NCT07838493
Oromucosal Oxytocin and Vasopressin Modulation of Emotional Face Attention
currently recruiting participants · register updated 2026-09-24
2023-506826-36-00
A randomized, placebo-controlled, double-blind, 3-period cross-over study in youth with autism spectrum disorders evaluating neura
no status recorded · register updated 2026-09-23
2024-519383-40-00
Assessing Oxytocin's Role in Mitigating Psychosocial Stress in Breast Cancer Survivors
no status recorded · register updated 2026-09-11
NCT07815496
The Effects of Oxytocin on Fairness Perception and Related Prosocial Behaviors
currently recruiting participants · register updated 2026-09-11
NCT06039878
Mother-Baby Study - Observational
running, but no longer enrolling · register updated 2026-09-09
2024-512387-56-00
A randomized, placebo-controlled, double-blind, 2-period cross-over study in youth with autism spectrum disorders evaluating socia
no status recorded · register updated 2026-09-04

All peptides · Method

WEEKLY

Register Watch, weekly

New trials, approvals and enforcement actions. One email a week.